Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Perimeter Medical Imaging Ai Inc TSX Venture: PINK-X

Today's Change
Volume
Real-Time Last Update TSX Venture Last Sale

More stories below advertisement

Latest Press Releases

CORRECTION: Biotechs Working on Potential Preventive Measures and Cancer Treatments
- PR Newswire - PRF - Thu Apr 22, 9:30AM CDT
PR Newswire - PRF - CMTX
Thu Apr 22, 9:30AM CDT
, /PRNewswire/ -- Cancer research and development are a major part of the biotechnology industry, and there is always room for improvement and growth. Recently, biotech company revealed a revolutionary way for surgeons to be able to assess if a cancer has been fully removed, while still in the operating room. , andare also leading companies with an exceptional background in cancer research and are working constantly to introduce their latest innovations in preventing and/or providing solutions for cancer immunotherapies.
Clinical Trials Critical for the Evaluation of Advanced Medical Imaging Tools
- PR Newswire - PRF - Wed Apr 14, 7:50AM CDT
PR Newswire - PRF - CMTX
Wed Apr 14, 7:50AM CDT
, /PRNewswire/ -- Image-guided surgery offers surgeons greater control of the procedure and real-time feedback, thus providing better outcomes for patients. Accuracy in surgical procedures is critical for serious or life-threatening conditions, such as cancer, and medical technology companies are providing imaging tools to help surgeons deliver better results to their patients. Companies such as (TSXV:PINK),(NYSE:BFLY),(NASDAQ:NDRA),(NYSE:ASXC), and (NASDAQ:AVGR) have engaged in the research and development of advanced imaging tools for use in different procedures. In addition to the development of these tools, these companies are seeking regulatory approval and collaborating in clinical studies that provide data on the application of these imaging tools.
Perimeter Medical Imaging AI Announces Important Milestone in ATLAS AI Project with Standalone AI Algorithm Achieving Key Performance Metrics
- BusinessWire - Wed Apr 14, 7:45AM CDT
BusinessWire - CMTX
Wed Apr 14, 7:45AM CDT
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced significant progress within its ATLAS AI Project, an initiative aimed at advancing Perimeter's next-gen artificial intelligence (AI) and machine learning tools through clinical development. Perimeter's proprietary "ImgAssist" AI technology has now been trained with more than 400 volumes of images of excised breast tissue collected during the first stage of its ATLAS AI project.
Rising Demand for Diagnostic Tools Fuels the Growing Medical Imaging Market
- PR Newswire - PRF - Tue Apr 6, 7:50AM CDT
PR Newswire - PRF - CMTX
Tue Apr 6, 7:50AM CDT
, /PRNewswire/ -- Medical diagnostic and imaging tools have played a critical role in the detection and early diagnosis of diseases such as cancer, which are less treatable in their later stages. The medical imaging and diagnostics industry is set to grow significantly in the future as more companies embrace artificial intelligence (AI) and machine learning (ML) in the design and development of their medical imaging and diagnostic tools. With the industry likely to grow to by 2027, top medical imaging device manufacturers like (TSXV:PINK) (OTCPK:PYNKF),(NASDAQ:HOLX),(NYSE:SYK),(NASDAQ:NNOX), and (NYSE:GE) are taking note and developing point-of-care diagnostic tools for the US market. Such tools improve the speed and efficiency of diagnosis by delivering results immediately rather than later.
BTV Investor Alert Video: Perimeter Medical Imaging AI, Inc. - US FDA 510K Clearance on O.C.T. Imaging System
- Newsfile Corp - Thu Apr 1, 1:05PM CDT
Newsfile Corp - CMTX
Thu Apr 1, 1:05PM CDT
Vancouver, British Columbia--(Newsfile Corp. - April 1, 2021) - Perimeter'srecent 510(k) clearance from the U.S. FDA enables them to bring its "commercial-ready" Optical Coherence Tomography (OCT) Imaging System to the U.S. market.
Biotechs Working on Potential Preventive Measures and Cancer Treatments
- PR Newswire - PRF - Tue Mar 30, 7:50AM CDT
PR Newswire - PRF - CMTX
Tue Mar 30, 7:50AM CDT
, /PRNewswire/ -- Cancer research and development are a major part of the biotechnology industry, and there is always room for improvement and growth. Recently, biotech company (TSX-V:PINK) (OTCPK:PYNKF)revealed a revolutionary way for surgeons to be able to assess if a cancer has been fully removed, while still in the operating room. (NASDAQ:SNDX), (NASDAQ:NKTR),(NASDAQ:SLS) and(NASDAQ:CLDX) are also leading companies with an exceptional background in cancer research and are working constantly to introduce their latest innovations in preventing and/or providing solutions for cancer immunotherapies.
Perimeter Medical Imaging AI to Participate in Upcoming Investor Conferences
- BusinessWire - Tue Feb 23, 8:00AM CST
BusinessWire - CMTX
Tue Feb 23, 8:00AM CST
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, announced today that Jeremy Sobotta, Perimeter's Chief Executive Officer, will participate in the following virtual investor conferences:
Perimeter Medical Imaging AI Announces Acceleration of Expiry Date of Warrants
- BusinessWire - Tue Feb 2, 2:22AM CST
BusinessWire - CMTX
Tue Feb 2, 2:22AM CST
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, announced today it has elected to exercise its right under the terms of a warrant indenture dated June 29, 2020 (the "Warrant Indenture") between the Company and Computershare Trust Company of Canada (the "Warrant Agent") to accelerate the expiry date of the warrants to purchase common shares of the Company ("Common Shares") issued on June 29, 2020 to investors in Perimeter's private placement financing of units completed on that day (the "Warrants"). Each Warrant is exercisable to acquire one Common Share at an exercise price of $2.00.
Perimeter Medical Imaging AI to Present at the 13th Annual LD Micro Main Event Investor Conference
- ACCESSWIRE - Fri Dec 11, 8:01AM CST
ACCESSWIRE - CMTX
Fri Dec 11, 8:01AM CST
TORONTO, ON / ACCESSWIRE / December 11, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, announced today that Jeremy Sobotta, Perimeter's Chief Executive Officer, will present a corporate overview at the 13th Annual LD Micro Main Event (virtual) investor conference on Monday, December 14, 2020 at 12:40 pm ET.
Perimeter Medical Imaging AI Announces Third Quarter 2020 Financial Results
- ACCESSWIRE - Mon Nov 23, 7:30AM CST
ACCESSWIRE - CMTX
Mon Nov 23, 7:30AM CST
TORONTO, ON / ACCESSWIRE / November 23, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, today reported financial results for its third quarter ending September 30, 2020 and provided an update on its operations.

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies